EDIT earnings: a positive outcome, +11.5%

On May 4, 2022, Editas Medicine, Inc. reached its earnings. The result was a positive outcome, and the stock moved +11.5% in the window around the event. It had already run -38.0% in the 30 days into the catalyst — the kind of pre-event run-up that often precedes binary readouts.